亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

2”-O-沒食子酰基金絲桃苷 CAS:53209-27-1

 
 
單價 面議對比
詢價 暫無
發(fā)貨 四川成都市付款后3天內(nèi)
品牌 鈉鈳鋰
過期 長期有效
更新 2021-11-25 12:22
 

成都鈉鈳鋰生物科技有限公司

企業(yè)會員第5年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明

nkl-01139

中文名稱:2′′-O-沒食子酰基金絲桃苷
英文名稱:2′′-O-Galloylhyperin
英文別稱: 2′′-O-Galloylhyperoside; Quercetin 3-β-galactoside-2′′-gallate
CAS號:53209-27-1
純度: HPLC≥98%

分子式:C28H24O16
分子量:616.48
外觀:黃色針狀結(jié)晶
沸點(diǎn):1106.9±65.0°C
密度:1.94±0.1克/立方厘米|條件:溫度:20°C
PKA:6.17±0.40 |條件:酸性最強(qiáng)溫度:25°C
提取來源:鹿蹄草
藥理藥效:有祛風(fēng)濕、強(qiáng)筋骨和止血等功能, 臨床用于治療高血壓、冠心病及脈管炎等。

規(guī)格:10mg,20mg,50mg;可根據(jù)客戶需求包裝、定制

儲存條件: 低溫,避光、干燥、密封

用途: 用于鑒別、含量測定、藥理實(shí)驗(yàn)、活性篩選等科研、實(shí)驗(yàn)室使用;不得直接用于人體

供應(yīng)商:成都鈉鈳鋰生物科技有限公司

舉報收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
甘草酸 CAS:1405-86-3 甘草酸銨 CAS:53956-04-0 甘草查爾酮A CAS:58749-22-7 甘草查爾酮B CAS:58749-23-8 甘草查爾酮C CAS:144506-14-9 重樓皂苷II CAS:50773-42-7 重樓皂苷III CAS:19057-60-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |